Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160


Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.

Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, de St Maurice AM, Currier JS, Williams PL.

AIDS Care. 2011 Jun;23(6):775-85. doi: 10.1080/09540121.2010.525617.


Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.

Roux P, Fugon L, Winnock M, Salmon-Céron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group.

Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.


Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

Grierson J, Koelmeyer RL, Smith A, Pitts M.

HIV Med. 2011 Oct;12(9):562-9. doi: 10.1111/j.1468-1293.2011.00928.x. Epub 2011 May 9.


Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.

Teixeira C, Dourado Mde L, Santos MP, Brites C.

AIDS Res Hum Retroviruses. 2013 May;29(5):799-804. doi: 10.1089/AID.2012.0296. Epub 2013 Feb 5.


Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems.

Kim TW, Palepu A, Cheng DM, Libman H, Saitz R, Samet JH.

AIDS Care. 2007 Sep;19(8):1039-47.


Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.

Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, Golub ET, Schwartz RM, Howard AA, Ponath C, Plankey MW, Levine AM, Grey DD.

AIDS. 2008 Jul 11;22(11):1355-63. doi: 10.1097/QAD.0b013e32830507f2. Erratum in: AIDS. 2008 Sep 12;22(14):i. Levine, Andrea [corrected to Levine, Alexandra M].


Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.

Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E.

PLoS One. 2012;7(5):e35547. doi: 10.1371/journal.pone.0035547. Epub 2012 May 1.


Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.

Weber R, Huber M, Battegay M, Stähelin C, Castro Batanjer E, Calmy A, Bregenzer A, Bernasconi E, Schoeni-Affolter F, Ledergerber B; Swiss HIV Cohort Study.

HIV Med. 2015 Mar;16(3):137-51. doi: 10.1111/hiv.12184. Epub 2014 Aug 15.


Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.

Cohn SE, Umbleja T, Mrus J, Bardeguez AD, Andersen JW, Chesney MA.

AIDS Patient Care STDS. 2008 Jan;22(1):29-40. doi: 10.1089/apc.2007.0053.


Association between use of specific drugs and antiretroviral adherence: findings from MACH 14.

Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, Golin CE, Bangsberg DR, Liu H.

AIDS Behav. 2013 Jan;17(1):142-7. doi: 10.1007/s10461-011-0124-7.


Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.

Naidoo P, Peltzer K, Louw J, Matseke G, McHunu G, Tutshana B.

BMC Public Health. 2013 Apr 26;13:396. doi: 10.1186/1471-2458-13-396.


Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa.

Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK.

BMC Clin Pharmacol. 2010 Sep 17;10:11. doi: 10.1186/1472-6904-10-11.


Factors associated with suboptimal adherence to antiretroviral therapy in Asia.

Jiamsakul A, Kumarasamy N, Ditangco R, Li PC, Phanuphak P, Sirisanthana T, Sungkanuparph S, Kantipong P, K C Lee C, Mustafa M, Merati T, Kamarulzaman A, Singtoroj T, Law M; TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M).

J Int AIDS Soc. 2014 May 16;17:18911. doi: 10.7448/IAS.17.1.18911. eCollection 2014.


Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS.

Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM.

BMC Public Health. 2014 Jan 10;14:27. doi: 10.1186/1471-2458-14-27.


Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.

Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):93-9. doi: 10.1097/QAI.0b013e3181900129.


Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.

Haberer JE, Musinguzi N, Boum Y 2nd, Siedner MJ, Mocello AR, Hunt PW, Martin JN, Bangsberg DR.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):386-92. doi: 10.1097/QAI.0000000000000737.


Alcohol use accelerates HIV disease progression.

Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A.

AIDS Res Hum Retroviruses. 2010 May;26(5):511-8. doi: 10.1089/aid.2009.0211.


Prevalence and correlates of alcohol use disorders during antiretroviral treatment in injection-driven HIV epidemics in Vietnam.

Tran BX, Nguyen N, Ohinmaa A, Duong AT, Nguyen LT, Van Hoang M, Vu PX, Veugelers PJ.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):39-44. doi: 10.1016/j.drugalcdep.2012.06.009. Epub 2012 Jun 29.

Items per page

Supplemental Content

Write to the Help Desk